» Articles » PMID: 38714963

Trends in Incidence and Survival of Childhood Cancers in Khon Kaen, Thailand (2000-2019): a Population-based Khon Kaen Cancer Registry Study

Overview
Publisher Biomed Central
Specialty Public Health
Date 2024 May 7
PMID 38714963
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In Thailand, the national health care system and nationwide standard treatment protocols have evolved over time, potentially influencing the trends in the incidence and survival rates of childhood cancers. However, further investigations are required to comprehensively study these trends in Khon Kaen, Thailand.

Methods: Childhood cancer patients aged 0-14 years (n = 541) who were diagnosed with one of the five most common cancers between 2000 and 2019 from the population-based Khon Kaen Cancer Registry were enrolled. Descriptive statistics were used to analyse the demographic data, which are presented as numbers, percentages, means, and standard deviations. The trends in incidence between 2000 and 2019, including age-standardized incidence rates (ASRs) and annual percent changes (APCs), were analysed using the Joinpoint regression model. Survival analysis was performed for 5-year relative survival rates (RSRs) according to the Pohar Perme estimator and Kaplan-Meier survival curves.

Results: The ASRs of the overall top 5 childhood cancer groups were 67.96 and 106.12 per million person-years in 2000 and 2019, respectively. Overall, the APC significantly increased by 2.37% each year for both sexes. The overall 5-year RSRs were 60.5% for both sexes, 58.2% for males, and 63.9% for females. The highest 5-year RSR was for germ cell tumours (84.3%), whereas the lowest 5-year RSR was for neuroblastoma (29.1%).

Conclusions: The incidence and survival rates of childhood cancers in Khon Kaen, Thailand, varied according to sex. The incidence trends increased over time, meanwhile, the relative survival rates rose to satisfactory levels and were comparable to those of other nations with similar financial status. The implementation of national health policies and adherence to national treatment guidelines have improved cancer diagnosis and treatment outcomes.

References
1.
Chalkidou K, Marquez P, Dhillon P, Teerawattananon Y, Anothaisintawee T, Gadelha C . Evidence-informed frameworks for cost-effective cancer care and prevention in low, middle, and high-income countries. Lancet Oncol. 2014; 15(3):e119-31. DOI: 10.1016/S1470-2045(13)70547-3. View

2.
Abuhamed J, Nikkila A, Raitanen J, Alimam W, Lohi O, Pitkaniemi J . Incidence trends of childhood central nervous system tumors in Finland 1990-2017. BMC Cancer. 2022; 22(1):784. PMC: 9290294. DOI: 10.1186/s12885-022-09862-0. View

3.
Paapsi K, Baburin A, Mikkel S, Magi M, Saks K, Innos K . Childhood cancer incidence and survival trends in Estonia (1970-2016): a nationwide population-based study. BMC Cancer. 2020; 20(1):30. PMC: 6954517. DOI: 10.1186/s12885-019-6510-7. View

4.
Fan Y, Zhang X, Gao C, Jiang S, Wu H, Liu Z . Burden and trends of brain and central nervous system cancer from 1990 to 2019 at the global, regional, and country levels. Arch Public Health. 2022; 80(1):209. PMC: 9482735. DOI: 10.1186/s13690-022-00965-5. View

5.
Brand N, Qu L, Chao A, Ilbawi A . Delays and Barriers to Cancer Care in Low- and Middle-Income Countries: A Systematic Review. Oncologist. 2019; 24(12):e1371-e1380. PMC: 6975966. DOI: 10.1634/theoncologist.2019-0057. View